Research library

Plain-language summaries of the peer-reviewed preclinical literature behind each research compound in our catalogue. Articles cover mechanisms of action, study designs, key findings, and the limitations of preclinical data.

For scientific reference only — not medical advice. All content is derived from peer-reviewed preclinical and in vitro research. Summaries are provided for scientific reference, not medical advice, diagnosis, or treatment. All compounds are for in vitro research use only. Not for human or veterinary consumption.

— IN DEVELOPMENT

Research library — launching May 2026

The Velox Peptides research library is under active development. Initial articles will cover:

  • BPC-157: Mechanisms of Action in Preclinical Angiogenesis Research — rodent studies of vascular tissue response, VEGF interaction, and mucosal protection.
  • Retatrutide and Multi-Receptor Metabolic Research — the triple-agonist pharmacology investigated in GLP-1 / GIP / glucagon pathway studies.
  • Peptide Reconstitution — A Technical Guide — bacteriostatic water, concentration calculations, and handling best practice.
  • Understanding HPLC Purity in Research Peptides — how HPLC testing works, what a certificate of analysis documents, and how to read one.
  • Semax and BDNF Pathway Activity in Preclinical Neuroscience — the Eastern European research tradition and key findings.
  • MOTS-c and Mitochondrial Pathway Research — the mitochondrially-encoded peptide investigated for AMPK activation and metabolic signalling.

Articles will publish on a weekly cadence. To be notified when articles publish, email veloxpeps@gmail.com.

Browse the compound catalogue

Every compound page includes a research overview, specification table, and batch testing summary.

View compounds →
Compliance statement. Velox Peptides supplies research reagents for in vitro use by qualified researchers. Every compound is sold strictly as a research reagent. No product is a medicinal product within the meaning of the Human Medicines Regulations 2012. No product has been evaluated by the MHRA or FDA. No product is intended for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition. Any use outside lawful scientific research is outside the scope of sale. See our Research Use Policy and MHRA Statement.